This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.
|
OHSU to provide new, FDA-approved gene therapy for a form of blindnessOHSU will be one of just four institutions nationwide to initially provide a new gene therapy treatment for a form of blindness that affects both children and adults.
|
|
This email was sent to you by Oregon Health & Science University 3181 S.W. Sam Jackson Park Rd. | Portland, Oregon 97239-3098 |